Foresite Life Sciences Corp.

Foresite Life Sciences Corp. is a blank-check special purpose acquisition company sponsored by Foresite Capital Management, a San Francisco-based investment firm focused on the healthcare and life sciences sector. The company filed an S-1/A registration statement amendment with the SEC on May 6, 2021, under accession number 0001213900-21-024933, as part of its IPO process, placing its formation in the 2021 SPAC vintage. The vehicle was structured to target merger candidates in the life sciences and biopharmaceutical industries, aligning with Foresite Capital's core investment thesis around healthcare innovation and therapeutics development. For complete filing history, deal status, and analytical data on Foresite Life Sciences Corp. and hundreds of other SPACs, create your free account at SpacDesk.